1. Home
  2. PZZA vs NNNN Comparison

PZZA vs NNNN Comparison

Compare PZZA & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Papa John's International Inc.

PZZA

Papa John's International Inc.

HOLD

Current Price

$37.86

Market Cap

1.3B

ML Signal

HOLD

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

N/A

Current Price

$32.20

Market Cap

1.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PZZA
NNNN
Founded
1984
2021
Country
United States
Germany
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.5B
IPO Year
1993
2025

Fundamental Metrics

Financial Performance
Metric
PZZA
NNNN
Price
$37.86
$32.20
Analyst Decision
Buy
Analyst Count
9
0
Target Price
$49.44
N/A
AVG Volume (30 Days)
685.3K
33.4K
Earning Date
02-26-2026
04-28-2026
Dividend Yield
4.90%
N/A
EPS Growth
N/A
N/A
EPS
1.14
0.06
Revenue
$2,086,399,000.00
$6,920,153.00
Revenue This Year
$2.60
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$32.99
$584.00
Revenue Growth
N/A
N/A
52 Week Low
$30.16
$5.18
52 Week High
$55.74
$55.65

Technical Indicators

Market Signals
Indicator
PZZA
NNNN
Relative Strength Index (RSI) 36.21 53.52
Support Level $38.10 $27.32
Resistance Level $40.50 $35.45
Average True Range (ATR) 1.15 3.97
MACD -0.07 -0.10
Stochastic Oscillator 15.20 53.09

Price Performance

Historical Comparison
PZZA
NNNN

About PZZA Papa John's International Inc.

Papa John's is one of the largest players in the global QSR, or quick-service restaurant, pizza market, boasting more than 6,000 restaurants across nearly 50 countries at the end of 2024. The firm operates a predominantly franchised system, owning 9% of its restaurants and generating revenue from franchise royalties, sales of pizza and related products at its company-owned stores, and sales from its commissary supply chain. The firm is the fourth-largest limited-service pizza chain globally and third in the US (Euromonitor International), with a sizable presence in the UK, China, South Korea, and Chile.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

Share on Social Networks: